Trials / Conditions / Pleomorphic Variant Mantle Cell Lymphoma
Pleomorphic Variant Mantle Cell Lymphoma
3 registered clinical trials studyying Pleomorphic Variant Mantle Cell Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed NCT05861050 | City of Hope Medical Center | Phase 1 / Phase 2 |
| Active Not Recruiting | Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma NCT03946878 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Ce NCT02427620 | M.D. Anderson Cancer Center | Phase 2 |